H. Guan
发表
P. Seeman,
H. Niznik,
H. Guan,
1989,
Synapse.
P. Seeman,
H. Guan,
H. Hirbec,
2009,
Synapse.
P. Seeman,
H. Niznik,
O. Civelli,
1992,
Nature.
H. V. Van Tol,
H. V. Tol,
H. Guan,
1999,
Pharmacogenetics.
Susan R. George,
Philip Seeman,
Roger K. Sunahara,
1991,
Nature.
Philip Seeman,
Roger K. Sunahara,
R. Sunahara,
1991,
Nature.
R. Sunahara,
P. Seeman,
H. Niznik,
1992,
European journal of pharmacology.
P. Seeman,
H. Guan,
2008,
Synapse.
P. Seeman,
H. Guan,
2009,
Synapse.
Glutamate agonist LY404,039 for treating schizophrenia has affinity for the dopamine D2High receptor
P. Seeman,
H. Guan,
2009,
Synapse.
A. Bulloch,
R. Sunahara,
P. Seeman,
1993,
Proceedings of the National Academy of Sciences of the United States of America.
H. V. Van Tol,
H. Guan,
O. Schoots,
1998,
FEBS letters.
P. Seeman,
H. Niznik,
H. Guan,
1990,
Archives of general psychiatry.
P. Seeman,
H. V. Van Tol,
H. Guan,
1995,
European journal of pharmacology.
P Riederer,
K. Jellinger,
G. Reynolds,
1987,
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.
Philip Seeman,
Peter Riederer,
Kurt Jellinger,
1987,
Synapse.
P. Seeman,
H. Guan,
2007,
European journal of pharmacology.
H. V. Van Tol,
A. Petronis,
J. Bunzow,
1994,
Molecular pharmacology.
P. Seeman,
H. V. Tol,
H. Guan,
1993,
Nature.
P. Seeman,
H. V. Van Tol,
H. Guan,
1995,
European Journal of Pharmacology.
D. Grandy,
H. V. Van Tol,
O. Civelli,
1995,
European journal of pharmacology.
P. Seeman,
H. Niznik,
H. V. Van Tol,
1993,
Synapse.
Link between D1 and D2 dopamine receptors is reduced in schizophrenia and Huntington diseased brain.
P. Seeman,
G. Booth,
H. Niznik,
1989,
Proceedings of the National Academy of Sciences of the United States of America.
H. V. Van Tol,
S. Sanyal,
H. Guan,
1996,
Biochemistry.
J. Nobrega,
E. Borrelli,
P. Seeman,
1997,
Synapse.
P. Seeman,
H. V. Van Tol,
H. Guan,
1994,
Journal of medicinal chemistry.